Pharmacological approaches to the treatment of aphasiaFootnote

Support was provided by a Department of Veterans Affairs Research Grant.

References

• Albert, M.L., Bachman, D.L., Morgan, A., & Helms- Eastabrook, N. (1988). Pharmacotherapy for aphasia. Neurology, 38, 877–879.
   Google Scholar
• Bachman, D.L., & Morgan, A. (1988). The role of pharmacotherapy in the treatment of aphasia: Preliminary results. Aphasiology, 2, 225–228.
   Google Scholar
• Berger, B., Tassin, J.P., Blanc, G., Moyne, M.A., & Thiery, A.M. (1974). Histochemical confirmation of the dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways. Brain Research, 81, 332–337.
   Google Scholar
• Berger, B., Trottier, S., Vemey, C., Gaspar, P., & Alvarez, C. (1988). Regional and laminar distribution of the dopamine and seratonin innervation in the macaque cerebral cortex: A radiographic study. Journal of Comparative Neurology, 273, 99–119.
   Google Scholar
• Bergman, P.S., & Green, M. (1951). Aphasia: Effects of intravenous sodium amytal. Neurology, 1, 471–475.
   Google Scholar
• Billow, B.W.(1949). Observation of the use of sodium amytal in the treatment of aphasia. Medical Records, 162, 12–13.
   Google Scholar
• Brown, R.M., Ljunggren, B., Siejo, B.K., & Snider, S.R. (1974). Effect of ischemia on monoamine metabolism in the brain. Acta Physiology Scandinavia, 90, 789–791.
   Google Scholar
• Catsman-Berrevoets, C.E., & Harkskamp, F.V. (1988). Compulsive presleep behavior and apathy due to bilateral thalamic stroke. Neurology, 38, 647–649.
   Google Scholar
• Clark, I.N., & Mankikar, G.D. (1979). d-Amphetamine in elderly patients refractory to rehabilitation procedures. Journal of the American Geriatric Society, 4, 174–177.
   Google Scholar
• Cohen, M.P., Waltz, A.G., & Jacobson, R.L. (1975). Catecholamine content of cerebral tissue after occlusion or manipulation of the middle cerebral artery in cats. Journal of Neurosurgery, 43, 32–36.
   Google Scholar
• Cooper, J.R., Bloom, F.E., & Roth, R.H. (1991). The biochemical basis of neuropharmacology (6th ed.). New York, NY: Oxford University Press.
   Google Scholar
• Crisostomo, E.A., Duncan, P.W., Propst, M., Dawson, D.V., & Davis, J.N. (1988). Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Annals of Neurology, 23, 94–97.
   Google Scholar
• Darley, F.L., Keith, R.L., & Sasanuma, S. (1977). The effect of alerting and tranquilizing drugs upon performance of aphasic patients. In R.H. Brookshire (Ed.), Clinical aphasiology: Conference proceedings 1977. Minneapolis, MN: BRK.
   Google Scholar
• De Keyser, J., Claeys, A., De Backer, J.P., Edinger, G., Roels, F., & Vanquelin, G. (1988). Autoradiographic localization of the D1 and D2 dopamine receptors in human brain. Neuroscience Letter, 91, 142–147.
   Google Scholar
• De Keyser, J., Herregodts, P., & Edinger, G. (1990). The mesoneocortical dopamine neuron system. Neurology, 40, 1660–1662.
   Google Scholar
• Echiverri, H.C., Tatum, W.O., Merens, T.A., & Coker, S.B. (1988). Akinetic mutism: Pharmacologic probe of the dopaminergic mesencenphalofrontal activating system. Pediatric Neurology, 4, 228–230.
   Google Scholar
• Feeney, D., Gonzales, J., & Law, W. (1982). Amphetamine, heloperidol and experience interact to affect rate of recovery after motor cortex injury. Science, 217, 855–857.
   Google Scholar
• Goetz, C.G. (1990). Dopaminergic agonists in the treatment of Parkinson's disease. Neurology, 40, 50–54.
   Google Scholar
• Goodglass, H., & Kaplan, E. (1983). Boston Diagnostic Aphasia Examination. Malvern, PA: Lea & Febiger.
   Google Scholar
• Gupta, S.R., & Mlcoch, A.G. (1992). Bromocriptine treatment of nonfluent aphasia. Archives of Physical Medicine and Rehabilitation, 373–376.
   Google Scholar
• Hoffman, B.B., & Lefkowitz, J. (1990). Catecholamine and sympathominergic drugs. In A. Goodman, A. Gilman, T.W. Ralk, A.S. Nies, & P. Taylor (Eds.), The pharmacological basis of therapeutics. Elmsford, NY: Pergamon Press.
   Google Scholar
• Hovda, D.A., & Feeney, D. (1984). Amphetamine and experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Research, 298, 358–361.
   Google Scholar
• Hurwitz, B.E., Dietrich, W.D., & McCabe, P.M. (1991). Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex. Stroke, 22, 648–654.
   Google Scholar
• Kaplan, E., Goodglass, H" & Weintraub, S. (1983). Boston Naming Test. Malvern, PA: Lea & Febiger.
   Google Scholar
• Kertesz, A. (1982). Western Aphasia Battery. Toronto, Canada: Grune & Stratton.
   Google Scholar
• LaPointe, L.L. (1983). Aphasia interventions with adults: Historical, present and fiiture approaches. In J. Miller and D. Yoder (Eds.), Contemporary issues in language inter-vention: ASHA reports 12. Rockville, MD: American. Speech-Language-Hearing Association.
   Google Scholar
• Lidow, M.S., Goldman-Rakic, P.S., Rakic, P., & Innis, R.B. (1989). Dopamine D2 Receptors in the cerebral cortex: Distribution and pharmacological characterization with [3H] raclopride. Proceedings of the National Academy of Science USA, 86, 6412–6416.
   Google Scholar
• Linn, L. (1947). Sodium amytal in treatment of aphasia. Archives of Neurology, 58, 357–358.
   Google Scholar
• Linn, L., & Stein, M. (1946). The use of sodium amytal in the treatment of aphasia. Bulletin of the U.S. Army Medical Department, 5, 705–708.
   Google Scholar
• MacLennan, D.L., Nicholas, L.E., Morley, G.K., & Brookshire, R.H. (1991). The effects of bromocriptine on speech and language function in a patient with transcortical motor aphasia. In T.E. Prescott (Ed.), Clinical aphasiology: vol. 20. Boston, MA: College Hill.
   Google Scholar
• Robinson, R.G. (1976). Limbic influences on human speech. Annals ofthe New YorkAcademy of Science, 280,761–771.
   Google Scholar
• Sabe, W., Leiguarda, R., & Starkstein, S.E. (1992). An open label trail of bromocriptine in nonfluent aphasia. Neurology, 42, 1637–1638.
   Google Scholar
• Walker-Batson, D., Devous, M.D., Curtis, S.S., Unwin, H., & Greenlee, R.G. (1991). Response to amphetamine to facilitate recovery from aphasia subsequent to stroke. In T.E. Prescott (Ed.), Clinical aphasiology: vol. 20. Boston, MA: College Hill.
   Google Scholar
• Walker-Baston, D., Unwin, H., Curtis, S., Allen, E.,, Wood, M., & Smith, P. (1992). Use of amphetamines in the treatment of aphasia. Restorative Neurology and Neurosciences, 4, 47–50.
   Google Scholar
• Wertz, R.T., Collins, M.J., Weiss, D., Kurtzke, J.F., Friden, T., Brookshire, R.H., Pierce, J., Holtzapple, P., Hubbard, D.J., Porch, B.E., West, J.H., Davis, L., Matovitch, V., Morley, G.K., & Reserreccion, E. (1981). Veterans Administration Cooperative Study on Aphasia: A comparison of individual and group treatment. Journal of Speech and Hearing Research, 24, 580–594.
   Google Scholar
• West, R., & Stockel, S. (1965). The effect of meprobamate on recovery from aphasia. Journal of Speech and Hearing Research, 8, 56–62.
   Google Scholar